Cargando…
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693539/ https://www.ncbi.nlm.nih.gov/pubmed/33304282 http://dx.doi.org/10.3389/fpsyt.2020.576877 |
_version_ | 1783614767891480576 |
---|---|
author | Woelfl, Timo Rohleder, Cathrin Mueller, Juliane K. Lange, Bettina Reuter, Anne Schmidt, Anna Maria Koethe, Dagmar Hellmich, Martin Leweke, F. Markus |
author_facet | Woelfl, Timo Rohleder, Cathrin Mueller, Juliane K. Lange, Bettina Reuter, Anne Schmidt, Anna Maria Koethe, Dagmar Hellmich, Martin Leweke, F. Markus |
author_sort | Woelfl, Timo |
collection | PubMed |
description | The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's antipsychotic properties suggests that it may attenuate effects induced by THC. Thus, we investigated and compared the effects of THC and CBD administration on emotion, cognition, and attention as well as the impact of CBD pre-treatment on THC effects in healthy volunteers. We performed a placebo-controlled, double-blind, experimental trial (GEI-TCP II; ClinicalTrials.gov identifier: NCT02487381) with 60 healthy volunteers randomly allocated to four parallel intervention groups, receiving either placebo, 800 mg CBD, 20 mg THC, or both cannabinoids. Subjects underwent neuropsychological tests assessing working memory (Letter Number Sequencing test), cognitive processing speed (Digit Symbol Coding task), attention (d2 Test of Attention), and emotional state (adjective mood rating scale [EWL]). Administration of CBD alone did not influence the emotional state, cognitive performance, and attention. At the same time, THC affected two of six emotional categories—more precisely, the performance-related activity and extraversion—, reduced the cognitive processing speed and impaired the performance on the d2 Test of Attention. Interestingly, pre-treatment with CBD did not attenuate the effects induced by THC. These findings show that the acute intake of CBD itself has no effect per se in healthy volunteers and that a single dose of CBD prior to THC administration was insufficient to mitigate the detrimental impact of THC in the given setting. This is in support of a complex interaction between CBD and THC whose effects are not counterbalanced by CBD under all circumstances. |
format | Online Article Text |
id | pubmed-7693539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76935392020-12-09 Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers Woelfl, Timo Rohleder, Cathrin Mueller, Juliane K. Lange, Bettina Reuter, Anne Schmidt, Anna Maria Koethe, Dagmar Hellmich, Martin Leweke, F. Markus Front Psychiatry Psychiatry The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's antipsychotic properties suggests that it may attenuate effects induced by THC. Thus, we investigated and compared the effects of THC and CBD administration on emotion, cognition, and attention as well as the impact of CBD pre-treatment on THC effects in healthy volunteers. We performed a placebo-controlled, double-blind, experimental trial (GEI-TCP II; ClinicalTrials.gov identifier: NCT02487381) with 60 healthy volunteers randomly allocated to four parallel intervention groups, receiving either placebo, 800 mg CBD, 20 mg THC, or both cannabinoids. Subjects underwent neuropsychological tests assessing working memory (Letter Number Sequencing test), cognitive processing speed (Digit Symbol Coding task), attention (d2 Test of Attention), and emotional state (adjective mood rating scale [EWL]). Administration of CBD alone did not influence the emotional state, cognitive performance, and attention. At the same time, THC affected two of six emotional categories—more precisely, the performance-related activity and extraversion—, reduced the cognitive processing speed and impaired the performance on the d2 Test of Attention. Interestingly, pre-treatment with CBD did not attenuate the effects induced by THC. These findings show that the acute intake of CBD itself has no effect per se in healthy volunteers and that a single dose of CBD prior to THC administration was insufficient to mitigate the detrimental impact of THC in the given setting. This is in support of a complex interaction between CBD and THC whose effects are not counterbalanced by CBD under all circumstances. Frontiers Media S.A. 2020-11-13 /pmc/articles/PMC7693539/ /pubmed/33304282 http://dx.doi.org/10.3389/fpsyt.2020.576877 Text en Copyright © 2020 Woelfl, Rohleder, Mueller, Lange, Reuter, Schmidt, Koethe, Hellmich and Leweke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Woelfl, Timo Rohleder, Cathrin Mueller, Juliane K. Lange, Bettina Reuter, Anne Schmidt, Anna Maria Koethe, Dagmar Hellmich, Martin Leweke, F. Markus Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title | Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title_full | Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title_fullStr | Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title_full_unstemmed | Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title_short | Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers |
title_sort | effects of cannabidiol and delta-9-tetrahydrocannabinol on emotion, cognition, and attention: a double-blind, placebo-controlled, randomized experimental trial in healthy volunteers |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693539/ https://www.ncbi.nlm.nih.gov/pubmed/33304282 http://dx.doi.org/10.3389/fpsyt.2020.576877 |
work_keys_str_mv | AT woelfltimo effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT rohledercathrin effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT muellerjulianek effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT langebettina effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT reuteranne effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT schmidtannamaria effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT koethedagmar effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT hellmichmartin effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers AT lewekefmarkus effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers |